Cargando…
The amyloid beta ion channel hypothesis of Alzheimer’s disease
Alzheimer’s disease (AD) is a leading cause of chronic dementia in the US. Its incidence is increasing with an attendant increase in associated health care costs. Since its first description in a patient by Dr. Alois Alzheimer over a century ago, a large body of biomedical literature has established...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656296/ https://www.ncbi.nlm.nih.gov/pubmed/19300589 |
_version_ | 1782165489511825408 |
---|---|
author | Shirwany, Najeeb A Payette, Daniel Xie, Jun Guo, Qing |
author_facet | Shirwany, Najeeb A Payette, Daniel Xie, Jun Guo, Qing |
author_sort | Shirwany, Najeeb A |
collection | PubMed |
description | Alzheimer’s disease (AD) is a leading cause of chronic dementia in the US. Its incidence is increasing with an attendant increase in associated health care costs. Since its first description in a patient by Dr. Alois Alzheimer over a century ago, a large body of biomedical literature has established a detailed clinical and molecular profile of this disorder. Amyloid β peptide (Aβ; a 39–42 amino acid molecule) is the major component of senile plaques, the lesions that are one of the pathologic hallmarks of AD (Wong et al 1985). Although many aspects of the biology of amyloid β have been investigated, several fundamental questions about how this peptide causes AD neuropathology remain unanswered. The key question is: How is Aβ toxic to cerebral neurons? Because plaques are extra-neuronal deposits, it is difficult to imagine a structural basis for their toxicity. As an interesting contrast the other pathognomonic feature of AD, neurofibrillary tangles, are intra-axonal structural anomalies that are composed of the hyperphosphorylated microtubule associated (MAP) protein, tau. This review will assess the current thinking that relates to a recent hypothesis of Aβ toxicity. In 1992, Hardy and Higgins reported findings that suggested a new and intriguing possibility. These authors found that Aβ peptides disrupt Ca(2+) homeostasis in neurons and increase intracellular Ca(2+) [Ca(2+)](i). This was corroborated by Mattson and his colleagues who demonstrated that Aβ exposure to human cortical neurons raised [Ca2(+)](i) (Mattson, Cheng et al 1992); (Hardy and Higgins 1992). Finally, Nelson Arispe’s group at the NIH specifically investigated the possibility that Aβ peptides might function like Ca(2+) ion channels (Arispe et al 1993). This and several subsequent studies have laid the foundation for a novel idea: “Aβ peptides are, in part, toxic to neurons because they form aberrant ion channels in neuronal membranes and thereby disrupt neuronal homeostasis”. In this review we shall critically examine this theory in light of classic and contemporary literature. |
format | Text |
id | pubmed-2656296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-26562962009-03-19 The amyloid beta ion channel hypothesis of Alzheimer’s disease Shirwany, Najeeb A Payette, Daniel Xie, Jun Guo, Qing Neuropsychiatr Dis Treat Reviews Alzheimer’s disease (AD) is a leading cause of chronic dementia in the US. Its incidence is increasing with an attendant increase in associated health care costs. Since its first description in a patient by Dr. Alois Alzheimer over a century ago, a large body of biomedical literature has established a detailed clinical and molecular profile of this disorder. Amyloid β peptide (Aβ; a 39–42 amino acid molecule) is the major component of senile plaques, the lesions that are one of the pathologic hallmarks of AD (Wong et al 1985). Although many aspects of the biology of amyloid β have been investigated, several fundamental questions about how this peptide causes AD neuropathology remain unanswered. The key question is: How is Aβ toxic to cerebral neurons? Because plaques are extra-neuronal deposits, it is difficult to imagine a structural basis for their toxicity. As an interesting contrast the other pathognomonic feature of AD, neurofibrillary tangles, are intra-axonal structural anomalies that are composed of the hyperphosphorylated microtubule associated (MAP) protein, tau. This review will assess the current thinking that relates to a recent hypothesis of Aβ toxicity. In 1992, Hardy and Higgins reported findings that suggested a new and intriguing possibility. These authors found that Aβ peptides disrupt Ca(2+) homeostasis in neurons and increase intracellular Ca(2+) [Ca(2+)](i). This was corroborated by Mattson and his colleagues who demonstrated that Aβ exposure to human cortical neurons raised [Ca2(+)](i) (Mattson, Cheng et al 1992); (Hardy and Higgins 1992). Finally, Nelson Arispe’s group at the NIH specifically investigated the possibility that Aβ peptides might function like Ca(2+) ion channels (Arispe et al 1993). This and several subsequent studies have laid the foundation for a novel idea: “Aβ peptides are, in part, toxic to neurons because they form aberrant ion channels in neuronal membranes and thereby disrupt neuronal homeostasis”. In this review we shall critically examine this theory in light of classic and contemporary literature. Dove Medical Press 2007-10 /pmc/articles/PMC2656296/ /pubmed/19300589 Text en © 2007 Dove Medical Press Limited. All rights reserved |
spellingShingle | Reviews Shirwany, Najeeb A Payette, Daniel Xie, Jun Guo, Qing The amyloid beta ion channel hypothesis of Alzheimer’s disease |
title | The amyloid beta ion channel hypothesis of Alzheimer’s disease |
title_full | The amyloid beta ion channel hypothesis of Alzheimer’s disease |
title_fullStr | The amyloid beta ion channel hypothesis of Alzheimer’s disease |
title_full_unstemmed | The amyloid beta ion channel hypothesis of Alzheimer’s disease |
title_short | The amyloid beta ion channel hypothesis of Alzheimer’s disease |
title_sort | amyloid beta ion channel hypothesis of alzheimer’s disease |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656296/ https://www.ncbi.nlm.nih.gov/pubmed/19300589 |
work_keys_str_mv | AT shirwanynajeeba theamyloidbetaionchannelhypothesisofalzheimersdisease AT payettedaniel theamyloidbetaionchannelhypothesisofalzheimersdisease AT xiejun theamyloidbetaionchannelhypothesisofalzheimersdisease AT guoqing theamyloidbetaionchannelhypothesisofalzheimersdisease AT shirwanynajeeba amyloidbetaionchannelhypothesisofalzheimersdisease AT payettedaniel amyloidbetaionchannelhypothesisofalzheimersdisease AT xiejun amyloidbetaionchannelhypothesisofalzheimersdisease AT guoqing amyloidbetaionchannelhypothesisofalzheimersdisease |